Dysregulation of cannabinoid CB1 receptor expression in subcutaneous adipocytes of obese individuals

Animal Cells and Systems

Volumn 13, Issue 4, 2009, Pages 371-379

  Lee, Yong Ho ^a,d   Tharp, William G ^a   Dixon, Anne E ^a   Spaulding, Laurie ^a   Trost, Susanne ^a   Nair, Saraswathy ^b   Permana, Paska A ^c   Pratley, Richard E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

^c Phoenix Veterans Affairs Health Care System   (United States)

^d Catholic University of Daegu   (South Korea)

Author keywords

Adipocyte; Adipose tissue; CB1 receptor; Endocannabinoid; Obesity; Real time PCR

Indexed keywords

EID: 79955396058     PISSN: 19768354     EISSN: 21512485     Source Type: Journal    
DOI: 10.1080/19768354.2009.9647232     Document Type: Article

References (32)

1. Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR, and Tanaka M (2006) Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain 124: 175-183
2. Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offertaler L, Mackie K, Rudd MA, Bukoski RD, and Kunos G (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110: 1996-2002
3. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, and Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63: 908-914
4. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, Batkai S, Pacher P, Schon MR, Jordan J, and Stumvoll M (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060
5. Cavuoto P, McAinch AJ, Hatzinikolas G, Janovska A, Game P, and Wittert GA (2007) The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem Biophys Res Commun 364: 105-110
6. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, and Pagotto U (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431
7. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, and Ferla G (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125: 1393-1395
8. D'Eon TM, Pierce KA, Roix JJ, Tyler A, Chen H, and Teixeira SR (2008) The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 57: 1262-1268
9. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, and Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825
10. Duncan M, Davison JS, and Sharkey KA (2005) Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22: 667-683
11. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, Batkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, and Jordan J (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843
12. Flegal KM, Carroll MD, Ogden CL, and Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288: 1723-1727
13. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, and Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202
14. Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Peleraux A, Penarier G, Soubrie P, Le Fur G, Galiegue S, and Casellas P (2005) The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 19: 1567-1569
15. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, and Permana PA (2005) Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammationrelated genes. Diabetologia 48: 1776-1783
16. Lee YH and Pratley RE (2005) The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5: 70-75
17. Lee YH, Tokraks S, Pratley RE, Bogardus C, and Permana PA (2003) Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulinsensitive Pima Indians by differential display PCR. Diabetologia 46: 1567-1575
18. Nair S, Lee YH, Rousseau E, Cam M, Tataranni PA, Baier LJ, Bogardus C, and Permana PA (2005) Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 48: 1784-1788
19. Nong L, Newton C, Cheng Q, Friedman H, Roth MD, and Klein TW (2002) Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J Neuroimmunol 127: 169-176
20. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, Harvey-White J, Mackie K, Offertaler L, Wang L, and Kunos G (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305
21. Pagotto U, Vicennati V, Pasquali R (2005) The endocannabinoid system and the treatment of obesity. Ann Med 37: 270-275
22. Park B, Gibbons HM, Mitchell MD, and Glassa M (2003) Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 24: 473-478
23. Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova De Courten B, and Tataranni PA (2004) Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 286: E958-E962
24. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884
25. Porcella A, Maxia C, Gessa GL, and Pani L (2000) The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci 12: 1123-1127
26. Ralevic V (2003) Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol 472: 1-21
27. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP and Soubrie P (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345-R353
28. Ruan H, Zarnowski MJ, Cushman SW, and Lodish HF (2003) Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 278: 47585-47593
29. Ruiz-Llorente L, Sanchez MG, Carmena MJ, Prieto JC, Sanchez-Chapado M, Izquierdo A, and Diaz-Laviada I (2003) Expression of functionally active cannabinoid receptor CB1 in the human prostate gland. Prostate 54: 95-102
30. Tharp WG, Lee YH, Maple RL, and Pratley RE (2008) The cannabinoid CB1 receptor is expressed in pancreatic deltacells. Biochem Biophys Res Commun 372: 595-600
31. Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, and Rossner S (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-1397
32. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808